• 1
    Billing JS, Wells FC. Delays in the diagnosis and surgical treatment of lung cancer. Thorax 1996; 51: 9036
  • 2
    Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. Br Med J 1997; 314: 46771
  • 3
    Roncoroni L, Pietra N, Violi V, Sarli L, Choua O, Peracchia A. Delay in the diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Oncol 1999; 25: 1738DOI: 10.1053/ejso.1998.0622
  • 4
    Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999; 79: 85864
  • 5
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999; 353: 111926
  • 6
    Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 1999; 353: 11325
  • 7
    Anonymous. Registrations of cancer diagnosed in 1993–96, England and Wales. Office for National Statistics. Health Statistics Quarterly, Winter, 1999
  • 8
    Bloom HJG, Hendry WF, Wallace DM, Skeet RG. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 1982; 54: 13651
  • 9
    Shearer RJ, Chilvers CED, Bloom HJG, Bliss JM, Horwich A, Babiker A. Adjuvant chemotherapy in T3 carcinoma of the bladder. Br J Urol 1988; 62: 55864
  • 10
    International Collaboration of Triallists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet 1999; 354: 53340
  • 11
    Spurgeon P, Barwell F, Kerr D. Waiting times for cancer patients in England after general practitioner's referrals: retrospective national survey. Br Med J 2000; 320: 8389
  • 12
    Macarthur C, Pendleton LL, Smith A. Treatment delay in patients with bladder tumours. J Epidemiol Comm Health 1985; 39: 636
  • 13
    Payne P. Sex, age, history, tumour type and survival. In WallaceDM ed. Tumours of the Bladder. Edinburgh, London: E&S Livingstone Ltd 1959
  • 14
    Wallace DM, Harris DL. Delay in treating bladder tumours. Lancet 1965; ii: 3324
  • 15
    Mommsen S, Aagaard J, Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol 1983; 17: 1637
  • 16
    Stower MJ. Delays in diagnosing and treating bladder cancer. Br Med J 1988; 296: 12289
  • 17
    Gulliford MC, Petruckevitch A, Burney PGJ. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. Br Med J 1991; 303: 43740
  • 18
    Dickinson AJ, Howe K, Bedford C, Sanders T, Prentice A, Sibley GNA. A retrospective study of the investigation and management of muscle-invasive bladder cancer in the South West Region. Br J Urol 1996; 77: 705
  • 19
    Lynch TH, Waymont B, Dunn JA, Hughes MA, Wallace DMA. Rapid diagnostic service for patients with haematuria. Br J Urol 1994; 73: 14751
  • 20
    Sorahan T, Hamilton L, Wallace DMA, Bathers S, Gardiner K, Harrington JM. Occupational urothelial tumours: a regional case-control study. Br J Urol 1998; 82: 2532
  • 21
    Hermanek P, Sobin LH, eds. UICC TNM Classification of Malignant Tumours. 4th edn. Berlin, Heidelberg, New York, London, Paris, Tokyo: Springer-Verlag, 1987
  • 22
    Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and example. Br J Cancer 1977; 35: 139
  • 23
    Cox DR. Regression models and life tables. J Roy Stat Soc [B] 1972; 34: 187220
  • 24
    Sorahan T, Lancashire RJ, Sole G. Urothelial cancer and cigarette smoking: findings from a regional case-controlled study. Br J Urol 1994; 74: 7536
  • 25
    Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer. an analysis of 315 cases. J Urol 1982; 127: 2502
  • 26
    Heney NM, Ahmed S, Flanagan MJ et al. Superficial bladder cancer. Progression and recurrence. J Urol 1983; 130: 10836
  • 27
    Van Der Meijden A, Sylvester R, Collete L, Bono A, Ten Kate F. The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of five European Organization for Research and Treatment of Cancer trials. J Urol 2000; 164: 15337
  • 28
    Herr HW. The value of second transurethral resection in evaluating patients with bladder tumors. J Urol 1999; 162: 746
  • 29
    Lynch TH, Waymont B, Dunn JA, Wallace DMA. Urologists' attitudes to the management of bladder cancer. Br J Urol 1992; 70: 5225


  1. Authors

D.M.A. Wallace, FRCS, Consultant Urological Surgeon.

R.T. Bryan, MRCS, MRC Research Fellow.

J.A. Dunn, MSc, Senior Statistician.

G. Begum, BSc, Statistician.

S. Bathers, MMedSci, Senior Trial Co-ordinator.


interquartile range.